240
Participants
Start Date
October 21, 2024
Primary Completion Date
April 30, 2026
Study Completion Date
January 31, 2027
Bimagrumab
Administered SC
Tirzepatide
Administered SC
Bimagrumab Placebo
Administered SC
Tirzepatide Placebo
Administered SC
Keystone Clinical Studies, Plymouth Meeting
Clinical Neuroscience Solutions, Inc. dba CNS Healthcare, Jacksonville
Suncoast Research Group, Miami
Altus Research, Lake Worth
Central Research Associates, Birmingham
Pinnacle Research Group, LLC, Anniston
SKY Integrative Medical Center/SKYCRNG, Ridgeland
Great Lakes Clinical Trials - Ravenswood, Chicago
Diablo Clinical Research, Inc., Walnut Creek
East-West Medical Research Institute, Honolulu
Eastside Research Associates, Redmond
Rainier Clinical Research Center, Renton
Eli Lilly and Company
INDUSTRY